Rapport Therapeutics Insider Trades
NASDAQ: RAPPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 2 · $143.27K
- Shares bought / sold
- 0 / 4.52K
- Net activity
- Net selling $143,273
Rapport Therapeutics insider activity
Over the last 12 months, Rapport Therapeutics insiders reported 2 transactions on SEC Form 4: 0 open-market purchases and 2 sales. Insiders bought $0 and sold $143,273 worth of stock, for net insider selling of $143,273. The largest seller was Ceesay Abraham, with $143,273 in reported sales.
The most recent filing shows Ceesay Abraham (Chief Executive Officer) selling 1,147 shares at $30.66 on Oct 7, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RAPP's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
RAPP insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 7, 2026 | Ceesay AbrahamChief Executive Officer | Sale | 1,147 | $35.17K | Form 4 |
| Oct 6, 2026 | Ceesay AbrahamChief Executive Officer | Sale | 3,375 | $108.11K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4